Please use this identifier to cite or link to this item:
Title: N-acetylglucosamine increases the efficacy of quercetin in the treatment of experimental acute kidney injury
Authors: Shebeko, S. K.
Zupanets, I. A.
Propisnova, V. V.
Шебеко, С. К.
Зупанець, І. А.
Зупанец, И. А.
Прописнова, В. В.
Keywords: acute kidney injury;N-acetylglucosamine;nephroprotective effect;quercetin
Issue Date: 2020
Bibliographic description (Ukraine): Shebeko, S. K. N-acetylglucosamine increases the efficacy of quercetin in the treatment of experimental acute kidney injury / S. K. Shebeko, I. A. Zupanets, V. V. Propisnova // Journal of Pharmacy & Pharmacognosy Research. - 2020. - Vol. 8, Iss. 1. - P. 53-56.
Abstract: Context: Acute kidney injury (AKI) is a common complication of renal pathology and an adverse drug effect. Mortality caused by AKI reaches 80% in some groups of patients. Therefore, the search of the effective agents for AKI treatment is an important task of the pharmaceutical science. Aims: To evaluate the efficacy of various combinations of N-acetylglucosamine (NAG) and quercetin in rats with AKI. Methods: The study was conducted on the model of acute glycerol ne-phrosis in rats. Combinations of NAG and quercetin in ratios of 1:2, 1:1, 2:1 and 3:1 were studied at a dose of 50 mg/kg with daily intramuscular injection for a week. The efficacy of the combinations was assessed by the indicators of animal survival, excretory renal function, nitrogen metabolism and nephroprotective activity (NA). Results: The combination of NAG and quercetin in the 1:1 ratio was the most effective. There was a significant increase of excretory renal function and normalization of nitrogen metabolism under the influence of this combination. This determined the NA level up to 69.7%, which was the highest value in the presented study. This combination was statistically superior to all others, as well as to quercetin, by the efficacy level. In addition, the combination exceeded the quercetin in NA index by 2.7 times. Conclusions: Thus, the NAG/quercetin combination in 1:1 ratio in injectable dosage form is the most promising for kidney diseases treatment.
ISSN: 0719-4250
Appears in Collections:Наукові публікації кафедри клінічної фармакології та клінічної фармації

Files in This Item:
File Description SizeFormat 
jppres19.689_8.1.53.pdf864,62 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.